← SynDRA
HEXOPRENALINE
SynDRA canonical compound SYN0025602 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | ADRB2 |
| Mechanism of action | adrenergic receptor agonist |
| Indication | asthma |
| Disease area | pulmonary |
All known targets
Mechanisms of action (all sources)
- adrenergic receptor agonist
Drug classes
- Adrenergic Agents
- Adrenergic Agonists
- Adrenergic beta-2 Receptor Agonists
- Adrenergic beta-Agonists
- Anti-Asthmatic Agents
- Bronchodilator Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Reproductive Control Agents
- Respiratory System Agents
- Tocolytic Agents
ATC classes
- R03C · ADRENERGICS FOR SYSTEMIC USE
- R03A · ADRENERGICS, INHALANTS
Cross-references
Synonyms
- delaprem
- ipradol
- hexoprenaline hydrochloride
- hexoprenaline dihydrochloride
- hexoprenaline sulfate
- hexoprenaline HCl
- Hexoprenalina
- Ipradol
- ST-1512
- ST1512
- Esoprenalina
- Hexoprenalinum
- St 1512
- hexoprenalina
- St1512
- G9L6B3W684
- RefChem:146315
- DTXCID5028297
- R03AC06
- R03CC05
- Hexoprenaline (INN)
- HEXOPRENALINE [INN]
- Esoprenalina [DCIT]
- Hexoprenalino
- Hexoprenaline [INN:BAN]
- Hexoprenalinum [INN-Latin]
- Hexoprenalino [INN-Spanish]
- NCGC00167522-01
- Hexoprenalin
- UNII-G9L6B3W684
- Ipradol (TN)
- 1,12-Bis(3,4-dihydroxyphenyl)-3,10-diaza-1,12-dodecandiol
- HEXOPRENALINE [MI]
- SCHEMBL121449
- HEXOPRENALINE [WHO-DD]
- orb1702203
- SCHEMBL32668781
- AKOS040746895
Look up HEXOPRENALINE in the interactive SynDRA portal →